Human Cytomegalovirus Suppresses Estrogen and Progesterone Receptor Expression in Hormone Receptor-Positive Breast Cancer Cells: Implications for Endocrine Resistance
Cancers · 06.08.2026 · 18 (15) · 2519
DOI: 10.3390/cancers18152519 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 06.08.2026. Verfasst von Erica C Garcia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biology, Texas Woman's University, Denton, TX 76204, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Texas Woman's University, Research Enhancement Program at TWU, Biology Faculty Development Funds.
Abstract (Originalsprache)
Background
Hormone receptor-positive breast cancer depends on estrogen and progesterone signaling, yet factors that modulate hormone receptor expression within tumors remain incompletely understood. Human cytomegalovirus (HCMV), a widespread herpesvirus detected in breast tumors, has been associated with reduced expression of estrogen receptor-α (ERα) and progesterone receptor (PR), but a direct causal relationship has not been established.
Methods
ER+/PR+ breast cancer cell lines MCF-7 and T47D were infected with HCMV in vitro. ERα and PR protein levels were assessed by immunoblotting, and transcript levels of ESR1 and PGR were quantified by qPCR. To determine whether virus replication was required, parallel experiments used UV-inactivated HCMV.
Results
HCMV infection resulted in a marked reduction in ERα and PR protein levels in both cell lines, accompanied by decreased ESR1 and PGR transcript levels by 48 h post-infection. Notably, UV-inactivated HCMV produced a comparable suppression of hormone receptor expression, indicating that viral gene expression and productive replication are not required for this effect.
Conclusions
These findings indicate that HCMV exposure suppresses ERα and PR expression in breast cancer cells through a replication-independent mechanism. This effect suggests that viral components or host responses to infection may alter hormone receptor signaling within tumors, with potential implications for hormone receptor signaling and endocrine therapy responsiveness that warrant further investigation. Together, these results identify HCMV as a previously underrecognized modulator of hormone receptor pathways in breast cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Biology, Texas Woman's University, Denton, TX 76204, USA.
- Department of Pediatrics, Weill Cornell Medicine, New York, NY 10065, USA.
- School of Natural & Environmental Sciences, College of Charleston, Charleston, SC 29424, USA.
ORCID-Profile: Erica C Garcia, Juliet V Spencer
Förderung
- Texas Woman's University
- Research Enhancement Program at TWU
- Biology Faculty Development Funds
- Paup Foundation
- Jane Nelson Institute for Women’s Leadership
- TWU Center for Student Research
Zitieren
APA
Garcia, E. C., LaRue, I. J., Griggs, N. D., & Spencer, J. V. (2026). Human Cytomegalovirus Suppresses Estrogen and Progesterone Receptor Expression in Hormone Receptor-Positive Breast Cancer Cells: Implications for Endocrine Resistance. Cancers, 18(15), 2519. https://doi.org/10.3390/cancers18152519
Vancouver
Garcia EC, LaRue IJ, Griggs ND, Spencer JV. Human Cytomegalovirus Suppresses Estrogen and Progesterone Receptor Expression in Hormone Receptor-Positive Breast Cancer Cells: Implications for Endocrine Resistance. Cancers. 2026;18(15):2519. doi:10.3390/cancers18152519
BibTeX
@article{Garcia2026,
author = {Garcia, Erica C and LaRue, Ian J and Griggs, Nathan D and Spencer, Juliet V},
title = {Human Cytomegalovirus Suppresses Estrogen and Progesterone Receptor Expression in Hormone Receptor-Positive Breast Cancer Cells: Implications for Endocrine Resistance},
journal = {Cancers},
year = {2026},
volume = {18},
number = {15},
pages = {2519},
doi = {10.3390/cancers18152519}
}
EUVIMED